StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report released on Monday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of BIOLASE stock opened at $0.01 on Monday. The stock’s 50 day simple moving average is $0.01 and its 200-day simple moving average is $0.02. The stock has a market cap of $287,300.20, a P/E ratio of 0.00 and a beta of 0.67. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.